Comparative proteomic studies of plasma from children with pneumococcal pneumonia

Scandinavian Journal of Infectious Diseases

Volumn 41, Issue 6-7, 2009, Pages 416-424

  Tsai, Ming Han ^a,b   Lin, Tzou Yien ^c,d   Hsieh, Sen Yung ^a,c   Chiu, Chih Yung ^a,b   Chiu, Cheng Hsun ^c,d   Huang, Yhu Chering ^c,d  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; HAPTOGLOBIN; IMMUNOGLOBULIN KAPPA CHAIN; PLASMA PROTEIN; PREALBUMIN;

AMINO ACID SEQUENCE; ARTICLE; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; EMPYEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFECTION COMPLICATION; INFLAMMATION; INNATE IMMUNITY; LUNG PARENCHYMA; MALE; MASS SPECTROMETRY; NECROSIS; OXIDATION; PLEURA FLUID; PNEUMONIA; PRESCHOOL CHILD; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEOMICS; STREPTOCOCCUS PNEUMONIA; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; BLOOD PROTEINS; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; INFANT; MALE; MASS SPECTROMETRY; PNEUMONIA; PNEUMONIA, PNEUMOCOCCAL; PROTEOME; PROTEOMICS; REPRODUCIBILITY OF RESULTS;

EID: 72149129994     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540902936909     Document Type: Article

References (26)

1. Tan TQ, Mason EO Jr, Barson WJ, Wald ER, Schutze GE, Bradley JS, et al. Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-non-susceptible Streptococcus pneumoniae. Pediatrics 1998;/102:/1369-75.
2. McCarthy VP, Patamasucon P, Gaines T, Lucas MA. Necrotizing pneumococcal pneumonia in childhood. Pediatr Pulmonol 1999;/28:/217-21.
3. Kerem E, Bar Ziv Y, Rudenski B, Katz S, Kleid D, Branski D. Bacteremic necrotizing pneumococcal pneumonia in children. Am J Respir Crit Care Med 1994;/149:/242-4.
4. McCarthy VP, Patamasucon P, Gaines T, Lucas MA. Necrotizing pneumococcal pneumonia in childhood. Pediatr Pulmonol 1999;/28:/217-21.
5. Chen KC, Su YT, Lin WL, Chiu KC, Niu CK. Clinical analysis of necrotizing pneumonia in children: 3-y experience in a single medical center. Acta Paediatr Tw 2003;/44:/343-8.
6. Hsieh YC, Hsueh PR, Lu CY, Lee PI, Lee CY, Huang LM. Clinical manifestations and molecular epidemiology of necrotizing pneumonia and empyema caused by Streptococcus pneumoniae in children in Taiwan. Clin Infect Dis 2004;/ 38:/830-5.
7. Wu TT, Hsueh PR, Lee LN, Yang PC, Luh KT. Pneumonia caused by penicillin-non-susceptible Streptococcus pneumoniae: clinical characteristics, prognostic factors, and outcomes. J Formos Med Assoc 2000;/99:/18-23.
8. Weiser JN, Kapoor M. Effect of intrastrain variation in the amount of capsular polysaccharide on genetic transformation of Streptococcus pneumoniae: implications for virulence studies of encapsulated strains. Infect Immun 1999;/67:/ 3690-3692
9. Wan J, Sun W, Li X, Ying W, Dai J, Kuai X, et al. Inflammation inhibitors were remarkably up-regulated in plasma of severe acute respiratory syndrome patients at progressive phase. Proteomics 2006;/6:/2886-94.
10. Hsieh SY, Shih TC, Yeh CY, Lin CJ, Chou YY, Lee YS. Comparative proteomic studies on the pathogenesis of human ulcerative colitis. Proteomics 2006;/6:/5322-31.
11. Hanash S. Disease proteomics. Nature 2003;/422:/226-32.
12. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002;/1:/845-67.
13. Gruys E, Toussaint MJM, Niewold TA, Koopmans SJ. Acute phase reaction and acute phase proteins. J Zhejiang Univ SCI 2005;/11:/1045-56.
14. Kadioglu A, Gingles NA, Grattan K, Kerr A, Mitchell TJ, Andrew PW. Host cellular immune response to pneumococcal lung infection in mice. Infect Immun 2000;/68:/ 492-501.
15. Yang F, Ghio AJ, Herbert DC, Weaker FJ, Walter CA, Coalson JJ. Pulmonary expression of the human haptoblogin gene. Am J Respir Cell Mol Biol 2000;/23:/277-82.
16. Balla J, Nath KA, Balla G, Juckett MB, Jacob HS, Vercellotti GM. Endothelial cell heme oxygenase and ferritin induction in rat lung by hemoglobin in vivo. Am J Physiol 1995;/268:/ 321-327
17. Yang F, Haile DJ, Berger FG, Herbert DC, Beveren EV, Ghio AJ. Haptoglobin reduces lung injury associated with exposure to blood. Am J Physiol Lung Cell Mol Physiol 2003;/284:/402-9.
18. Oh SK, Pavlotsky N, Tauber AI. Specific binding of haptoglobin to human neutrophils and its function consequences. J Leukoc Biol 1990;/47:/142-8.
19. Mateos-Cáceres PJ, García-Méndez A, López Farré A, Macaya C, Núñez A, Gómez J, et al. Proteomic analysis of plasma from patients during an acute coronary syndrome. J Am Coll Cardiol 2004;/44:/1578-83.
20. van Leeuwen HJ, Heezius EC, Dallinga GM, van Strijp JA, Verhoef J, van Kessel KP. Lipoprotein metabolism in patients with severe sepsis. Crit Care Med 2003;/31:/ 1359-1366
21. Levels JH, Abraham PR, van den Ende A, van Deventer SJ. Distribution and kinetics of lipoprotein-bound endotoxin. Infect Immun 2001;/69:/2821-8.
22. Levels JH, Abraham PR, van Barreveld EP, Meijers JC, van Deventer SJ. Distribution and kinetics of lipoprotein-bound lipoteichoic acid. Infect Immun 2003;/71:/3280-4.
23. Wu A, Hinds CJ, Thiemermann C. High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications. Shock 2004;/21:/210-21.
24. Chien JY, Jerng JS, Yu CJ, Yang PC. Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Crit Care Med 2005;/33:/1688-93.
25. Cohen J. The immunopathogenesis of sepsis. Nature 2002;/ 420:/885-91.
26. Fraunberger P, Pilz G, Cremer P, Werdan K, Walli AK. Association of serum tumor necrosis factor levels with decrease of cholesterol during septic shock. Shock 1998;/ 10:/359-63.